Cardiology

High-intensity statin effect independent of lipoprotein, CRP

(HealthDay)—High-intensity statin therapy is associated with coronary atherosclerosis regression, regardless of baseline lipoprotein or C-reactive protein (CRP) levels, according to a study published in the Nov. 15 issue ...

Cardiology

Mediterranean diet linked to lower left ventricular mass

(HealthDay)—Greater adherence to a Mediterranean-style diet (DT) is tied to a decreased left ventricular (LV) mass, according to a study published in the Feb. 15 issue of The American Journal of Cardiology.

Other

Good transplant outcomes in hypertrophic cardiomyopathy

(HealthDay) -- Post-heart transplant survival does not differ significantly between patients with hypertrophic cardiomyopathy (HC) and those with other types of heart disease, according to a study published in the Aug. 15 ...

Cardiology

Calculated LDL-C varies at lower values of measured LDL-C

(HealthDay)—At lower values of measured low-density lipoprotein cholesterol (LDL-C), the variation and bias of calculated LDL-C increases, according to a study published in the Aug. 15 issue of The American Journal of Cardiology.

Cardiology

Racial / ethnic differences in CHD outcomes not due to statins

(HealthDay)—For hospitalized patients with coronary heart disease (CHD), racial and ethnic differences in one-year outcomes are due to demographics and comorbidity, not differential statin prescriptions, according to a ...

Cardiology

Post-op myocardial necrosis common after orthopedic sx

(HealthDay)—Myocardial necrosis is common after orthopedic surgery and is associated with increased risk of long-term mortality, according to a study published in the June 15 issue of The American Journal of Cardiology.

Cardiology

Multiple factors motivate no reperfusion in STEMI

(HealthDay) -- For patients presenting with ST-segment elevation myocardial infarction (STEMI), the decision for no reperfusion is usually multifactorial, with the most common factor being advanced age, according to a study ...

Cardiology

Early prophylactic tx beneficial for hypertrophic cardiomyopathy

(HealthDay)—Beta blockers (BBs) are effective as an early prophylactic pharmacologic treatment for patients with mild hypertrophic cardiomyopathy (HC) who have exercise-induced left ventricular outflow tract (LVOT) obstruction, ...

page 5 from 13